What Is the Safe Observation Period Following Image-Guided Percutaneous Renal Biopsies?

影像引导下经皮肾穿刺活检后的安全观察期是多久?

阅读:1

Abstract

PURPOSE: To investigate the timing, type, and severity of complications following percutaneous, image-guided renal biopsy and to determine if the current observation period of 4 h can be safely reduced. METHODS: Consecutive image-guided percutaneous renal biopsies performed between 2017 and 2022 in adult patients by radiology medical staff were included. The RIS-PACS imaging systems and electronic medical records (EMR) were accessed to obtain relevant patient information and procedural reports. A retrospective analysis of the type and timing of complications was performed against patient demographics and biopsy-related variables. Probabilities were calculated for a range of observation periods to assess the proportion of complications identified by shortening the observation period from 4 h. RESULTS: Three hundred and thirty-two percutaneous renal biopsies were included, and 44 (13%) complications were identified within the 4 h observation. Twenty-nine complications were post-operative bleeding, of which 2 developed macroscopic haematuria, 25 peri-nephric haematoma and 2 had haemodynamic instability with either haematuria or peri-nephric haematoma. 64% of all complications occurred within the first hour, and 86% occurred within 2 h. Of the six complications occurring after 2 h, two were post-operative bleeding in non-targeted renal biopsies requiring admission, and the other four did not require additional observation/procedures. CONCLUSION: The vast majority of complications after targeted and non-targeted renal biopsies tend to occur within the first 2 h of observation. Complications that occurred after 2 h observation were often pain related, something that can be overcome with a standardised post-operative analgesic regime. It may be possible to safely reduce observation times following image-guided targeted renal biopsies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。